InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: ignatiusrielly35 post# 46382

Friday, 03/01/2019 6:42:07 PM

Friday, March 01, 2019 6:42:07 PM

Post# of 48316
Volume is pretty low so seems like price is being depressed to me. Market fears dilution right now. It sucks but Oncosec probably should have raised before SITC when price was touching $2. Oncosec has an ATM with Cantor but recently stated they have not used it and are at no obligation to do so. I suppose they could hold out for another 6 months before needing to tap the ATM. What investors need is a boost of faith such as a licensing deal for the new product candidate. It could be truly market disruptive....and maybe Big Pharma would jump in before trials begin. With another waiting period before either TNBC or PISCES updates Oncosec shares have been under pressure. Would be nice to get some more exciting announcements before AACR next month. A licensing deal for the multi-gene construct before trials get underway is not out of the question given that it looks extremely promising. A recent example of a huge licensing deal is the JNJ licensing deal with Locus Bio (private company) for more than $800 million and $20 million upfront. That is the kind of deal Oncosec needs right now with this new tech they are unveiling.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News